Stratasys Announces Enrollment is Now Open for 3DHEART Clinical Study on Effects of 3D Printed Heart Models in Pre-Operative Planning

Clinical study supported by Stratasys Corporate Social Responsibility (CSR) program MINNEAPOLIS & REHOVOT, Israel–March 08, 2017(–BUSINESS WIRE)–Stratasys Ltd. (Nasdaq:SSYS), the 3D printing and additive manufacturing solutions company, today announced enrollment is now open for 3DHEART, an investigator initiated trial. 3DHEART, which stands for 3D Hearts Read More »

Image courtesy of Stratasys Ltd.